GNI In-licenses Hepatitis Drug from EpiCept Corporation (EPCT)
7/22/2008 1:30:20 PM
More...
|
EpiCept Corporation (EPCT) and GNI Partner to Develop Anti-Viral Hepatitis Drug in Asia
7/17/2008 11:01:21 AM
More...
|
GNI and Shanghai Genomics, Inc. to Start China Clinical Trials of Liver Drug
11/21/2007 11:36:16 AM
More...
|
China Patent and Trademark Office Grants Patent for F351, GNI's Key Therapeutic Product for Liver Disease
11/7/2007 11:17:01 AM
More...
|
GNI Successfully Completes IPO
9/4/2007 12:51:24 PM
More...
|
GNI Sees Demand For Synthetic Bone Material Product In China
10/2/2006 11:47:46 AM
More...
|
GNI Identifies Important Reuglator And Associated Signaling Cascade In Human Immunological Disorders
9/20/2006 12:31:07 PM
More...
|